Skip to main content

Table 4 Cost parameters (2011 Norwegian Kroner (NOK), €1.00 = NOK8.01)

From: Choice of generic antihypertensive drugs for the primary prevention of cardiovascular disease - A cost-effectiveness analysis

Description

Value (€)

Cost of developing angina and have treatment

15,242

Cost of being in the state post MI for a year

331

Cost of being in the state post stroke for a year

292

Cost of being in the state post angina for a year

292

Cost of dying a cardiac death in hospital

5,169

Short term costs of developing heart failure

1,346

Cost of worsening of heart failure

4,598

Cost of one year with heart failure

3,569

Cost of living in the health state moderate stroke sequelae

6,436

Costs of treating a non-ST-elevated myocardial infarction

22,674

Cost of being in the health state severe stroke sequelae (i.e. one year in nursing home)

99,875

Cost of reinfarction

3,713

Costs treating an ST-elevated MI

22,674

Costs of getting stroke

23,546

Cost of one unit DRG

4,615

Cost of GP visits when receiving statin treatment (first year)

185

Cost of GP visits when receiving statin treatment (later years)

94

Cost of GP visits when receiving thiazide treatment (first year)

195

Cost of GP visits when receiving thiazide treatment (later years)

97

Yearly cost of thiazide (hydrochlorothiazide 12.5 mg*)

20

Yearly cost of ACE inhibitor (enalapril 20 mg)

58

Yearly cost of calsium channel blocker (Amlodipin 5 mg*)

30

Yearly cost of ARB (losartan 100 mg**)

73

Yearly cost of beta blocker (atenolol 50 mg***)

35

  1. *For hydrochlorothiazide and amlodipin we assumed half a pill each day
  2. **For losartan we assumed half a pill the first 6 days
  3. ***For atenolol, we assumed two pills per day